Selected discussion
Feasibility of Shallow Whole-Genome Sequencing-Based Circulating Tumour DNA Analysis in Canine Multicentric Lymphoma A Pilot Study.
Clinical evidence update from Veterinary and comparative oncology
Clinical Context Peer-reviewed veterinary literature continues to shape everyday decision-making for canine patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.
What the Study Evaluated A study published in Veterinary and comparative oncology in 2026 evaluated feasibility of Shallow Whole-Genome Sequencing-Based Circulating Tumour DNA Analysis in Canine Multicentric Lymphoma: A Pilot Study..
Key Findings Lymphoma is a common canine malignancy with high morbidity and variable prognosis. Circulating tumour DNA (ctDNA) has emerged as a minimally invasive biomarker for tumour burden, treatment response and prognosis in human lymphoma. However, the feasibility of applying shallow whole-genome sequencing (sWGS)-based ctDNA analysis to canine lymphoma remains unclear. In this pilot study, plasma cell-free DNA (cfDNA) was quantita…
Discussion thread
Community replies
Follow the line down to read the conversation in order.
No replies yet
No replies yet. Be the first professional to join this discussion.
Use the reply box above to start the conversation.


Join this discussion
Add your reply
Share a professional insight, ask a focused question, or add relevant clinical experience.
Member participation
Log in to join the discussion
Share an answer, ask a question, reply to another professional, or mark useful contributions as helpful.